Barry A Bunting

Summary

Publications

  1. ncbi The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia
    Barry A Bunting
    Mission Hospitals, Asheville, NC, USA
    J Am Pharm Assoc (2003) 48:23-31. 2008
  2. ncbi The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma
    Barry A Bunting
    Department of Pharmacy, Diabetes and Health Education Center, Mission Hospitals, Asheville, NC, USA
    J Am Pharm Assoc (2003) 46:133-47. 2006
  3. ncbi The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program
    Carole W Cranor
    University of North Carolina Chapel Hill, USA
    J Am Pharm Assoc (Wash) 43:173-84. 2003

Detail Information

Publications3

  1. ncbi The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia
    Barry A Bunting
    Mission Hospitals, Asheville, NC, USA
    J Am Pharm Assoc (2003) 48:23-31. 2008
    ..Assess clinical and economic outcomes of a community-based, long-term medication therapy management (MTM) program for hypertension (HTN)/dyslipidemia...
  2. ncbi The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma
    Barry A Bunting
    Department of Pharmacy, Diabetes and Health Education Center, Mission Hospitals, Asheville, NC, USA
    J Am Pharm Assoc (2003) 46:133-47. 2006
    ..To assess clinical, humanistic, and economic outcomes of a community-based medication therapy management (MTM) program for 207 adult patients with asthma over 5 years...
  3. ncbi The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program
    Carole W Cranor
    University of North Carolina Chapel Hill, USA
    J Am Pharm Assoc (Wash) 43:173-84. 2003
    ..To assess the persistence of outcomes for up to 5 years following the initiation of community-based pharmaceutical care services (PCS) for patients with diabetes...